Daniel Abdun-Nabi

Insider Reports History

Entity
Individual
Location
400 Professional Drive, Suite 400, Gaithersburg, MD
Signature
/s/ SoYoung Kwon, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Abdun-Nabi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Director Stock Option (Right to Buy) 10K Jun 4, 2021 Direct
Aptevo Therapeutics Inc. Director Restricted Stock Unit 925 Jul 17, 2024 Direct
Aptevo Therapeutics Inc. Director Common Stock 277 Jun 2, 2024 Direct
Aptevo Therapeutics Inc. Director Restricted Stock Unit 0 Jun 2, 2024 Direct

Insider Reports Filed by Daniel Abdun-Nabi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APVO Aptevo Therapeutics Inc. Jul 17, 2024 1 $0 4 Jul 19, 2024 Director
APVO Aptevo Therapeutics Inc. Jun 1, 2024 4 $0 4 Jun 3, 2024 Director
APVO Aptevo Therapeutics Inc. Aug 9, 2023 2 $0 4 Aug 10, 2023 Director
APVO Aptevo Therapeutics Inc. Jun 1, 2023 3 $0 4 Jun 2, 2023 Director
APVO Aptevo Therapeutics Inc. Aug 9, 2022 1 $0 4 Aug 10, 2022 Director
APVO Aptevo Therapeutics Inc. Jun 1, 2022 2 $0 4 Jun 3, 2022 Director
RGNX REGENXBIO Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
APVO Aptevo Therapeutics Inc. Jun 1, 2021 2 $0 4 Jun 2, 2021 Director
APVO Aptevo Therapeutics Inc. Aug 3, 2016 0 $0 4/A Mar 7, 2023 Director